According to OpenAI, immunologist Derya Unutmaz used GPT-5 Pro to crack a puzzle that had stumped him for three years. The work focused on T cell behavior, and the company says the model provided insights that had previously remained elusive.
The breakthrough offers a clearer picture of how T cells act, which OpenAI says could aid research into cancer and autoimmune diseases. The company frames the result as a demonstration of the model's potential in scientific discovery.
This account comes from a single source—OpenAI's own write-up—so there is no independent verification or contrasting viewpoint in the provided material. The claims are presented from the company's perspective.